LUNG

作品数:1661被引量:4184H指数:23
导出分析报告
相关作者:姜格宁蔡菊芬卢红阳马胜林徐作军更多>>
相关机构:北京协和医院首都医科大学附属北京胸科医院上海市肺科医院广西医科大学第一附属医院更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家重点基础研究发展计划中国博士后科学基金广东省自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Journal of Cancer Therapyx
条 记 录,以下是1-10
视图:
排序:
Multi-Metastatic Hepatoid Adenocarcinoma of the Lung: Report of Case
《Journal of Cancer Therapy》2022年第5期304-309,共6页Toky Rakotoarivo Christian Tomboravo Malala Razakanaivo Narindra Rajaonarison Ny Ony Clairette Raharisolo Florine Rafaramino 
Hepatoid adenocarcinoma of the lung is a rare tumor with a poor prognosis. There are no specific treatment-recommendations for this cancer. We report a 59-year-old man, a former smoker, with this condition. He present...
关键词:Hepatoid Adenocarcinoma LUNG Chemothérapy METASTASIS 
Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose
《Journal of Cancer Therapy》2021年第9期505-529,共25页Joshua R. Niska Jiuyun Hu Jing Li Michael G. Herman Cameron S. Thorpe Steven E. Schild Mirek Fatyga 
Purpose: Recent studies of radiotherapy (RT) for stage III non-small-cell lung cancer (NSCLC) have associated high dose to the heart...
关键词:Lung Cancer Cardiac Toxicity Lung Radiation Therapy Non-Small Cell Lung Cancer Radiation Toxicity 
Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
《Journal of Cancer Therapy》2021年第7期409-423,共15页Justin D. Anderson Jiuyun Hu Jing Li Steven E. Schild Mirek Fatyga 
Purpose: To examine possible association between heart irradiation and Overall Survival (OS) in lung SBRT patients and to com...
关键词:Lung Cancer Lung SBRT Cardiac Toxicity Lung Radiation Therapy Non-Small Cell Lung Cancer 
Biomarker Testing Rates in Patients with Advanced Non-Small Cell Lung Cancer Treated in the Community被引量:2
《Journal of Cancer Therapy》2019年第12期971-984,共14页Eric Nadler Melissa Pavilack Jamyia Clark Janet Espirito Ancilla Fernandes 
Introduction: Over the past few years, molecular targeted therapies have been?emerging for the treatment of metastatic non-small cell lung cancer (NSCLC).?Targeted therapy is associated with improved outcomes in patie...
关键词:Non-Small-Cell LUNG Cancer NSCLC Biomarkers EGFR TESTING 
Predictive Factors of Intracranial Response of Immune Checkpoint Inhibitors in Patients with Brain Metastasis from Non-Small Cell Lung Cancer
《Journal of Cancer Therapy》2019年第8期692-707,共16页Julien Bermudez Celine Mascaux Youssef Trigui Julie Biemar Mohamed Boucekine Laurent Greillier Fabrice Barlesi Pascale Tomasini 
Background: Immune checkpoint inhibitors (ICI)s were recently approved for the treatment of advanced non-small cell lung cancer (NSCLC). Whereas brain metastases (BM) are frequent in NSCLC patients, data are missing r...
关键词:LUNG Cancer Brain METASTASIS IMMUNOTHERAPY Efficacy Tolerance 
Correlation between the Changes in Lung Function and Lung Density Changes in Patients Following Radio- (Chemo-) Therapy for Thoracic Carcinomas
《Journal of Cancer Therapy》2019年第3期257-267,共11页Christina Schroeder Rita Engenhart-Cabillic Sven Kirschner Eyck Blank André Buchali 
Purpose: In this analysis we focused on the correlation of patients’ lung function (PFT) data and lung density changes (ΔHU) detected in follow-up CTs. Material and Methods: PFT and lung function data were available...
关键词:LUNG THORACIC NEOPLASMS Radiation Injuries Pulmonary Fibrosis LUNG Function 
Dual Epidermal Growth Factor Inhibition and Multi Targeted Epigenetic Therapy (MTET)
《Journal of Cancer Therapy》2018年第11期872-882,共11页Mohammad Nezami Steve Hager 
Since the discovery of tyrosine kinase inhibitors in treatment of lung cancer harboring such actionable targets, many lives have been prolonged. To the same extent, same group of patients have failed to benefit from t...
关键词:EPIDERMAL Growth Factor LUNG Cancer EPIGENETIC THERAPIES TARGETED THERAPIES AFATINIB 
Local Consolidation Therapy versus Observation for Oligometastatic Non Small Cell Lung Cancer Patients: Phase II Randomized Trial被引量:1
《Journal of Cancer Therapy》2018年第11期925-940,共16页Ghada Ezzat Eladawei Rasha Mohamed Abdellatif Sheref Mohamed El-Taher 
Background and Objective: Based on retrospective trials, most progression sites after first line systemic therapy for metastatic non small cell lung cancer (NSCLC) were the primary disease sites rather than new sites....
关键词:LUNG Cancer Oligometastatic CONFORMAL THORACIC RADIOTHERAPY 
A Retrospective Evaluation of Chemotherapy Regimens in Unselected Patients with Metastatic Non-Small Cell Lung Cancer被引量:1
《Journal of Cancer Therapy》2018年第3期314-322,共9页Ahmed Ashour Badawy Abbas Omar Waleed Arafat Gehan Khedr Sejong Bae Stefan Grant 
Background: Randomized clinical trials have demonstrated the benefits of chemotherapy in carefully selected non-small cell lung cancer (NSCLC) patients. How generalizable these results are to other NSCLC patients is u...
关键词:NSCLC-Lung Cancer Chemotherapy-Comorbidities 
A Biomechanical Model of Human Lung Deformation Utilizing Patient-Specific Elastic Property被引量:1
《Journal of Cancer Therapy》2016年第6期402-415,共14页Behnaz Seyfi Anand P. Santhanam Olusegun J. Ilegbusi 
A biomechanical model is developed and validated for breathing-induced deformation of human lung. Specifically, a subject-specific poro-elastic lung model is used to predict the displacement over the breathing cycle a...
关键词:Biomechanical Model Lung Deformation Image Registration 
检索报告 对象比较 聚类工具 使用帮助 返回顶部